Cited by 29Mangiferin and Mango ExtractsPharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Mangifera indica L. Extract and Mangiferin Modulate Cytochrome P450 and UDP‐Glucuronosyltransferase Enzymes in Primary Cultures of Human Hepatocytes

Rodeiro, Idania, José Gómez‐Lechón, M., Perez, Gabriela, Hernandez, Ivones, Herrera, José Alfredo, Delgado, Rene, Castell, José V., Teresa Donato, M.·2013·Phytotherapy Research

Abstract

The aqueous stem bark extract of Mangifera indica L. (MSBE) has been reported to have antioxidant, anti-inflammatory and analgesic properties. In previous studies, we showed that MSBE and mangiferin, its main component, lower the activity of some cytochrome P-450 (P450) enzymes in rat hepatocytes and human liver microsomes. In the present study, the effects of MSBE and mangiferin on several P450 enzymes and UDP-glucuronosyltransferases (UGTs) in human-cultured hepatocytes have been examined. After hepatocytes underwent a 48-h treatment with sub-cytotoxic concentrations of the products (50-250 µg/mL), a concentration-dependent decrease of the activity of the five P450 enzymes measured (CYP1A2, 2A6, 2C9, 2D6 and 3A4) was observed. For all the activities, a reduction of at least 50% at the highest concentration (250 µg/mL) was observed. In addition, UGT activities diminished. MSBE considerably reduced UGT1A9 activity (about 60% at 250 µg/mL) and lesser effects on the other UGTs. In contrast, 250 µg/mL mangiferin had greater effects on UGT1A1 and 2B7 than on UGT1A9 (about 55% vs. 35% reduction, respectively). Quantification of specific mRNAs revealed reduced CYP3A4 and 3A5 mRNAs content, and an increase in CYP1A1, CYP1A2, UGT1A1 and UGT1A9 mRNAs. No remarkable effects on the CYP2A6, 2B6, 2C9, 2C19, 2D6 and 2E1 levels were observed. Our results suggest that the activity and/or expression of major P450 and UGT enzymes is modulated by MSBE and that potential herb-drugs interactions…

Integrity signals

Registry

Crossref · 10.1002/ptr.4782

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Material standardization is uneven, with frequent use of extracts or nanoparticles without full reporting of purity, content uniformity, or release profiles.

    “Material standardization is uneven, with frequent use of extracts or nanoparticles without full reporting of purity, content uniformity or release profiles, making cross-study comparisons difficult and weakening conclusions regarding the active entity (161,181).”
  • Evaluation of drug-drug interaction risks for MGF is sparse.

    “ii) sparse evaluation of drug-drug interaction risks given pathway cross-talk (for example, with PI3K/Akt, AMPK or NF-κB modulators) (181-183)”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rodeiro, I., José Gómez‐Lechón, M., Perez, G., Hernandez, I., Herrera, J. A., Delgado, R., Castell, J. V., & Teresa Donato, M.
Affiliations
  • Departamento de Farmacología Centro de Bioproductos Marinos (CEBIMAR) Loma 37, Vedado 10400 Havana Cuba
  • Unidad de Hepatología Experimental Centro de Investigación, Hospital La Fe Avda Campanar 21 46009 Valencia Spain
  • University of Havana (CU)
  • Laboratorio Farmacología Molecular Centro de Investigación y Desarrollo de Medicamentos, 26 y 51 Plaza de la Revolución 10400 Havana Cuba
  • Universitat de València (ES)
Corresponding author
Rodeiro, Idania
Venue
Phytotherapy Research
Publisher
Wiley
Published
2012-07-20
Volume
27
Issue
5
Pages
745-752
ISSN
  • 0951-418X (ISSN-L)
  • 1099-1573
OpenAlex
W1849883515
Cited by
29
References
1
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2013: 2
FWCI
3.90
Type
journal article
Language
en
Open access
closed
Locations
  • Phytotherapy Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Mangiferin and Mango Extracts
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
mango, mangiferin, stem bark extract, cytochrome P450, UDP-glucuronosyltransferase, human hepatocytes, drug-metabolizing enzymes, herb-drug interactions, CYP3A4, UGT1A9, UGT1A1, CYP1A2, gene expression, ADMET properties
MeSH terms
Cells, Cultured, Cytochrome P-450 Enzyme System, Humans, Plant Extracts, Glucuronosyltransferase, Hepatocytes, Plant Bark, Mangifera

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review